Statements (47)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:genus
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Firmicutes
|
| gptkbp:analyzes |
its role in chronic diseases
|
| gptkbp:class |
gptkb:Clostridia
|
| gptkbp:cultural_practices |
fecal samples
|
| gptkbp:examines |
clinical microbiology
therapeutic potential its effects on metabolism |
| gptkbp:family |
gptkb:Lachnospiraceae
|
| gptkbp:has_role |
immune system modulation
metabolism of short-chain fatty acids |
| gptkbp:has_website |
gptkb:physicist
|
| https://www.w3.org/2000/01/rdf-schema#label |
Faecalibacterium
|
| gptkbp:increased |
healthy individuals
|
| gptkbp:is_affected_by |
gptkb:product
|
| gptkbp:is_analyzed_in |
gut microbiome profiling
|
| gptkbp:is_associated_with |
reduced inflammation
dietary fiber intake |
| gptkbp:is_characterized_by |
anaerobic metabolism
|
| gptkbp:is_considered |
a keystone species
a marker for gut health a potential probiotic |
| gptkbp:is_found_in |
human gut microbiome
|
| gptkbp:is_involved_in |
gut-brain axis
host-microbe interactions microbial balance |
| gptkbp:is_linked_to |
gptkb:healthcare_organization
mental health metabolic syndrome |
| gptkbp:is_monitored_by |
clinical studies
|
| gptkbp:is_part_of |
intestinal microbiota
probiotic research gut health assessments gut microbiota diversity microbiome therapies |
| gptkbp:is_studied_in |
microbiome research
its anti-inflammatory properties its role in health |
| gptkbp:is_used_in |
fecal microbiota transplantation
probiotic formulations |
| gptkbp:is_vulnerable_to |
some environmental stresses
|
| gptkbp:order |
gptkb:Clostridiales
|
| gptkbp:phylum |
gptkb:Firmicutes
|
| gptkbp:reduces |
obesity
|
| gptkbp:sensor |
antibiotics
|
| gptkbp:species |
gptkb:Faecalibacterium_prausnitzii
|